These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 18536780)
1. A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation. Jensen JT Drugs Today (Barc); 2008 Mar; 44(3):183-95. PubMed ID: 18536780 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Anderson FD; Gibbons W; Portman D Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561 [TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized study of an extended cycle oral contraceptive. Anderson FD; Hait H Contraception; 2003 Aug; 68(2):89-96. PubMed ID: 12954519 [TBL] [Abstract][Full Text] [Related]
4. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
5. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Kwiecien M; Edelman A; Nichols MD; Jensen JT Contraception; 2003 Jan; 67(1):9-13. PubMed ID: 12521651 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens. Darwish M; Bond M; Ricciotti N; Hsieh J; Fiedler-Kelly J; Grasela T Reprod Sci; 2014 Nov; 21(11):1401-10. PubMed ID: 24647707 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms. Jensen JT; Archer DF Expert Opin Pharmacother; 2008 Feb; 9(2):319-27. PubMed ID: 18201154 [TBL] [Abstract][Full Text] [Related]
8. Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers. Mueck AO; Seeger H; Petersen G; Schulte-Wintrop E; Wallwiener D Contraception; 2001 Dec; 64(6):357-62. PubMed ID: 11834234 [TBL] [Abstract][Full Text] [Related]
9. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive. Woutersz TB; Korba VD Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915 [TBL] [Abstract][Full Text] [Related]
15. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Larsson-Cohn U; Wallentin L; Zador G Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252 [TBL] [Abstract][Full Text] [Related]
16. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect]. Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064 [No Abstract] [Full Text] [Related]
17. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America. Moggia AV J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704 [TBL] [Abstract][Full Text] [Related]
18. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive. Kaunitz AM; Portman DJ; Hait H; Reape KZ Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846 [TBL] [Abstract][Full Text] [Related]
19. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study. Skouby SO Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346 [TBL] [Abstract][Full Text] [Related]
20. The 150/30 formulation. Experience in the United Kingdom. Guillebaud J J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]